The Impact of Yellow Laser Treatments on Erythema and Telangiectasia in Rosacea: A Systematic Review and Meta-Analysis

Focussed our study on Rosacea, a chronic inflammatory skin condition characterized by persistent facial erythema and telangiectasia, which can lead to significant psychosocial distress. Among its subtypes, erythematotelangiectatic rosacea (ETR) is particularly resistant to conventional treatments where aimed to this. This systematic review and meta-analysis evaluate the efficacy and safety of 577-nm pro-yellow laser treatments for reducing erythema and telangiectasia in rosacea patients, and refer method of our study refers to a comprehensive search across electronic databases that was conducted to identify relevant clinical studies. Inclusion criteria focused on studies involving patients with ETR treated with yellow laser therapies. Data on demographics, treatment parameters, and outcomes were extracted and analysed as well as The findings indicate that the 577-nm pro-yellow laser is effective in achieving significant reductions in erythema and telangiectasia, with a favourable safety profile characterized by mild and transient side effects, never less the treatment was well-tolerated, contributing to improved patient satisfaction and quality of life so finally we conclude Yellow laser therapy represents a promising treatment option for patients with rosacea, particularly those with vascular manifestations. Further research is necessary to establish long-term efficacy and optimal treatment protocols.